KaloBios Pharmaceuticals, Inc. Strengthens Development Expertise With Additions to Senior Management Team

PALO ALTO, Calif.--(BUSINESS WIRE)--KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced two additions to its senior management team that significantly increase the company’s intellectual property and regulatory expertise. Carol Stratford, Ph.D., J.D., who previously worked for Pfizer as Site Head of the Rinat Laboratories facility, joins KaloBios as General Counsel and Head of Intellectual Property. Charles Democko, previously Vice President, Regulatory Affairs and Development Operations at Novacea Inc., joins the company as Vice President, Regulatory Affairs and Quality.